Maysa Suyagh

470 total citations
22 papers, 344 citations indexed

About

Maysa Suyagh is a scholar working on Epidemiology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Maysa Suyagh has authored 22 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Maysa Suyagh's work include Adipokines, Inflammation, and Metabolic Diseases (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Maysa Suyagh is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Maysa Suyagh collaborates with scholars based in Jordan, United Kingdom and Canada. Maysa Suyagh's co-authors include Rana Abu Farha, Henry L. Halliday, James C. McElnay, Paul S. Collier, Prashant Kole, Jeff S. Millership, Violet Kasabri, Jeffrey S. Millership, Nailya Bulatova and Eman Alefishat and has published in prestigious journals such as PEDIATRICS, Analytical and Bioanalytical Chemistry and Journal of Hypertension.

In The Last Decade

Maysa Suyagh

21 papers receiving 339 citations

Peers

Maysa Suyagh
Maysa Suyagh
Citations per year, relative to Maysa Suyagh Maysa Suyagh (= 1×) peers Johanna Strandell

Countries citing papers authored by Maysa Suyagh

Since Specialization
Citations

This map shows the geographic impact of Maysa Suyagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maysa Suyagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maysa Suyagh more than expected).

Fields of papers citing papers by Maysa Suyagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maysa Suyagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maysa Suyagh. The network helps show where Maysa Suyagh may publish in the future.

Co-authorship network of co-authors of Maysa Suyagh

This figure shows the co-authorship network connecting the top 25 collaborators of Maysa Suyagh. A scholar is included among the top collaborators of Maysa Suyagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maysa Suyagh. Maysa Suyagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Soares, Nelson C., Muath Mousa, Violet Kasabri, et al.. (2022). Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS. Metabolites. 12(6). 508–508. 16 indexed citations
3.
Farha, Rana Abu, Eman Elayeh, Tareq L. Mukattash, et al.. (2021). Perception of pharmacy students towards their community pharmacy training experience: a cross-sectional study from Jordan. BMC Medical Education. 21(1). 161–161. 5 indexed citations
4.
Suyagh, Maysa, Mohammad Saleh, Salahdein Aburuz, et al.. (2021). Population Pharmacokinetics Modeling of Lamotrigine in Jordanian Epileptic Patients Using Dried Blood Spot Sampling. Drug Research. 71(8). 429–437. 1 indexed citations
5.
Tabbaa, Mohammad J., et al.. (2020). Prevalence of cardiovascular Diseases Risk Factors Among Jordanians. Journal of the Saudi Heart Association. 32(2). 324–333. 8 indexed citations
6.
Bulatova, Nailya, et al.. (2019). Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes. Bratislavské lekárske listy/Bratislava medical journal. 119(12). 762–769. 6 indexed citations
8.
Albsoul‐Younes, Abla, et al.. (2019). Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes. Hormone Molecular Biology and Clinical Investigation. 37(3). 4 indexed citations
9.
Bulatova, Nailya, et al.. (2019). Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes. Hormone Molecular Biology and Clinical Investigation. 37(3). 7 indexed citations
10.
Kasabri, Violet, et al.. (2019). Proportional correlates of adipolin and cathepsin S in metabolic syndrome patients with and without prediabetes. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 13(4). 2403–2408. 4 indexed citations
11.
Suyagh, Maysa, Eman Alefishat, Rana Abu Farha, et al.. (2018). The Impact of Shift Work-Related Circadian Rhythm Disruption on Inflammatory Biomarkers. Jordan Journal of Pharmaceutical Sciences. 11(2). 2 indexed citations
13.
Kasabri, Violet, et al.. (2018). Cross-sectional correlates of nesfatin and lipopolysaccharide binding protein in metabolic syndrome patients with and without prediabetes. Hormone Molecular Biology and Clinical Investigation. 36(3). 5 indexed citations
14.
Farha, Rana Abu, et al.. (2016). Parental views of antibiotic use in children with upper respiratory tract infections in Jordan. Tropical Journal of Pharmaceutical Research. 15(9). 2009–2009. 7 indexed citations
15.
Suyagh, Maysa, et al.. (2014). Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharmaceutical Journal. 23(2). 147–153. 93 indexed citations
16.
Farha, Rana Abu, et al.. (2014). Evidence‐based medicine use in pharmacy practice: a cross‐sectional survey. Journal of Evaluation in Clinical Practice. 20(6). 786–792. 21 indexed citations
17.
Suyagh, Maysa, Ahmed F. Hawwa, Paul S. Collier, et al.. (2013). Potassium canrenoate treatment in paediatric patients. Journal of Hypertension. 31(9). 1901–1908. 4 indexed citations
18.
Suyagh, Maysa, Ahmed F. Hawwa, Paul S. Collier, et al.. (2012). Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients. British Journal of Clinical Pharmacology. 74(5). 864–872. 5 indexed citations
19.
Suyagh, Maysa, Prashant Kole, Jeff S. Millership, et al.. (2010). Development and validation of a dried blood spot–HPLC assay for the determination of metronidazole in neonatal whole blood samples. Analytical and Bioanalytical Chemistry. 397(2). 687–693. 53 indexed citations
20.
Suyagh, Maysa, Prashant Kole, Jeff S. Millership, et al.. (2010). Development and validation of a dried blood spot—LC–APCI–MS assay for estimation of canrenone in paediatric samples. Journal of Chromatography B. 878(9-10). 769–776. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026